Grantclosed🌐 United StatesRFA-NS-23-017
Optimization of Genome Editing Therapeutics for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (U01 - Clinical Trials Not Allowed)
National Institutes of Health
Details?
- Posted
- Aug 24, 2022
- Response deadline
- Nov 30, 2022, 12:00 AM UTC
- Type
- Grant
- Category
- 93.866, 93.853
- Status
- closed
- Buyer
- National Institutes of Health
- Department
- HHS-NIH11
- Jurisdiction
- United States
- Reference #
- RFA-NS-23-017
- Doc Type
- synopsis
- Opp Status
- archived
Finding similar opportunities…
This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.
Raw record
{
"id": "343237",
"title": "Optimization of Genome Editing Therapeutics for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (U01 - Clinical Trials Not Allowed)",
"agency": "National Institutes of Health",
"number": "RFA-NS-23-017",
"docType": "synopsis",
"cfdaList": [
"93.866",
"93.853"
],
"openDate": "08/24/2022",
"closeDate": "11/30/2022",
"oppStatus": "archived",
"agencyCode": "HHS-NIH11"
}